"
Team:Carnegie Mellon/Safety
From 2013.igem.org
(Difference between revisions)
Enpederson (Talk | contribs) |
Enpederson (Talk | contribs) |
||
| Line 2: | Line 2: | ||
<br /> | <br /> | ||
<p align='center'><b> | <p align='center'><b> | ||
| - | Safety forms were approved on 9/18/13 by Julie McNamara and David Lloyd. | + | Safety forms were approved on 9/18/13 by Julie McNamara and David Lloyd. </b><br /> |
| + | </p> | ||
| + | <p align='center'><b> | ||
| + | We were given approval for the use of recombinant DNA molecules using Biosafety Level 1 (BSL-2) practices and containment by Carnegie Mellon University’s Institutional Biosafety Committee | ||
</b> | </b> | ||
</p> | </p> | ||
Revision as of 01:33, 19 September 2013
Safety forms were approved on 9/18/13 by Julie McNamara and David Lloyd.
We were given approval for the use of recombinant DNA molecules using Biosafety Level 1 (BSL-2) practices and containment by Carnegie Mellon University’s Institutional Biosafety Committee
